Clinical Trial Update: Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene [Phase 1]

View source ↗

Summary

Phase 1 study assessing how pharmacogenetic factors and coadministration with paroxetine and clarithromycin influence the pharmacokinetics of clomiphene.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation

Drugs mentioned

• CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)
• Paroxetine (Paroxetine hydrochloride)
• clarithromycin (clarithromycin)

Snippet

Sponsor: Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | Conditions: Anovulation, Disorder Due Cytochrome P450 CYP2D6 Variant | Phase 1 | Status: COMPLETED